Nasdaq

WARRINGTON, Pa., March 13, 2023 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company...

Any forward-looking statements that the Company makes in this press release speak only as of the date of this press release. The Company assumes no obligation to update forward-looking statements whether as a result of new information, future events or otherwise, after the date of this press release. The Company was previously notified by Nasdaq on June 3, 2022 that it was not in compliance with the minimum bid price rule because its common stock failed to meet the closing bid price of $1.00 or more for 30 consecutive trading days, as required by the Nasdaq Listing Rules. To regain compliance with the Rule, the Company was required to maintain a minimum closing bid price of $1.00 or more for at least 10 consecutive trading days. Such statements are based on information available to the Company as of the date of this press release and are subject to numerous important factors, risks and uncertainties that may cause actual events or results to differ materially from the Company’s current expectations. The Company may, in some cases, use terms such as "predicts," "believes," "potential," "proposed," "continue," "estimates," "anticipates," "expects," "plans," "intends," "may," "could," "might," "will," "should" or other words that convey uncertainty of future events or outcomes to identify these forward-looking statements.

Should this proposed listing happen, the company's shares of common stock will continue to trade on the Australian Securities Exchange (ASX) and it intends to ...

“We went from a company that reported a net loss of $75.2 million in fiscal year 2021 to exiting 2022 with net income in the fourth quarter.” “Although we are not seeking to raise capital as part of the Nasdaq listing, we are excited to expand the universe of potential investors to the United States.” “Fiscal year 2022 will go down as a watershed moment for Sezzle,” Youakim said in the Feb. [Charlie Youakim](https://www.linkedin.com/in/charlieyouakim/) said in the release. Should this proposed listing happen, the company’s shares of common stock will continue to trade on the Australian Securities Exchange (ASX) and it intends to enable it to be sold to United States buyers on the ASX as well, the payment platform said in a Monday (March 13) [Sezzle](https://sezzle.com/) intends to list shares of common stock on the Nasdaq Global Market.

Windtree Therapeutics (WINT) has received a Bid Price Compliance Letter from The Nasdaq informing Windtree that it has regained compliance with the minimum ...

[WINT](https://seekingalpha.com/symbol/WINT)) has received a Bid Price Compliance Letter from The Nasdaq informing Windtree that it has [regained compliance](https://seekingalpha.com/pr/19192555-windtree-regains-compliance-nasdaq)with the minimum bid price requirement under Nasdaq Listing Rule. - Windtree Therapeutics (NASDAQ: Windtree Therapeutics regains compliance with Nasdaq

Sezzle Inc., the purpose-driven payment platform, has announced its intent to list its shares of common stock for trading on the Nasdaq Global Market, ...

[SEC](https://nnn.ng/tag/sec/). [ASX-](https://nnn.ng/tag/asx/). [](https://nnn.ng/#:~:text=bloggers outreach) Similarly, the ASX will also review the removal of the Foreign Ownership Restricted ( [FOR](https://nnn.ng/tag/for/)) [United States](https://nnn.ng/tag/united-states/) (US) person prohibited tag from CDIs. This designation restricts any CDIs from being sold on ASX to US persons excluding The Company cautions investors to consider these risks when making investment decisions.

SZL intends to eliminate the Foreign Ownership Restricted United States person forbidden tag from the CDIs ahead of the Nasdaq listing. The company may go for a ...

Out of the US$1.2 million, US$0.25 million is insured by FDIC. But the overall value of the shareholding would not change. This tag has so far effectively stopped the sale of CDIs on the Australian Securities Exchange to US people except when an exemption was available. [, Sezzle said the company held US$1.2 million](https://kalkinemedia.com/au/stocks/technology/seven-asx-technology-companies-having-cash-deposits-with-silicon-valley-bank) of cash with the collapsed Silicon Valley Bank. On such listing, Sezzle’s common stock securities, signified by CHESS Depositary Interests (CDIs), will keep trading on the ASX. As of 1:00 pm, AEDT shares of the buy now pay later (BNPL) provider were trading up by 4.716% at AU$0.555, outperforming the broader ASX 200 index, which was down over 1.5% around that time.